Bioage Labs, INC. (BIOA) — 8-K Filings

8-K Filings (5)

• BioAge Labs Files 8-K on Financial Results & Reg FD Disclosure — Mar 24, 2026
  BioAge Labs, Inc. filed an 8-K on March 24, 2026, reporting on its results of operations and financial condition under Item 2.02, and making Regulation FD discl
• BioAge Labs Files 8-K Report — Dec 4, 2025 Risk: low
  On December 4, 2025, BioAge Labs, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and
• BioAge Labs Files 8-K on Shareholder Votes — Jun 9, 2025 Risk: low
  BioAge Labs, Inc. filed an 8-K on June 9, 2025, reporting on matters submitted to a vote of security holders as of June 5, 2025. The filing details the company'
• BioAge Labs Files 8-K Report — Jun 4, 2025 Risk: low
  On June 4, 2025, BioAge Labs, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific details regarding tra
• BioAge Labs Files 8-K: Material Agreement & Equity Sales — Sep 27, 2024 Risk: medium
  On September 25, 2024, BioAge Labs, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX